Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes.

Autor: Home, Philip, Derwahl, Karl-Michael, Ziemen, Monika, Wernicke-Panten, Karin, Pierre, Suzanne, Kirchhein, Yvonne, Garg, Satish K.
Zdroj: Diabetes Technology & Therapeutics; Feb2018, Vol. 20 Issue 2, p160-170, 11p
Databáze: Complementary Index